Pfizer, Inc. NYQ · PFE

Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?

The Motley Fool · 15h ago

NCLA Urges Supreme Court to Hear Vaccine Mandate Case that Clearly Misreads Precedent

GlobeNewswire Inc. · 1d ago

Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals

GlobeNewswire Inc. · 1d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates

GlobeNewswire Inc. · 3d ago

Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?

The Motley Fool · 4d ago

3 High-Yield Dividend Stocks Paying 5% or More That Are Worth Buying Now

The Motley Fool · 6d ago

NCLA to Fifth Circuit: Revive Suit Against Gov’t-Led Censorship of Covid Vaccine-Injured Americans

GlobeNewswire Inc. · 10d ago

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

The Motley Fool · 10d ago

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now

The Motley Fool · 11d ago

Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider

GlobeNewswire Inc. · 11d ago

Meet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July.

The Motley Fool · 12d ago

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

The Motley Fool · 15d ago

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

The Motley Fool · 16d ago

Big Pharma Has a Case of Merger Mania

The Motley Fool · 19d ago

AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

The Motley Fool · 19d ago

A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?

The Motley Fool · 20d ago

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

The Motley Fool · 21d ago

An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?

The Motley Fool · 23d ago

Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

GlobeNewswire Inc. · 23d ago

2 High-Yield Dividend Stocks to Buy and Hold for a Decade

The Motley Fool · 25d ago

Could Pfizer Stock Be Your Ticket to Generational Wealth?

The Motley Fool · 27d ago

Want to Retire on $500,000? 3 Stocks to Buy and Never Sell

The Motley Fool · 27d ago

Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?

The Motley Fool · 28d ago

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

The Motley Fool · 30d ago